Nuformix

Life Sciences

Pharmaceutical development company

  • Sector Life Sciences

Nuformix is a pharmaceutical development company using cocrystal technology, unlocking the therapeutic potential of approved drugs with lead programmes in oncology supportive care and fibrosis.

Nuformix has developed a risk-mitigated development pipeline targeting high-value unmet needs Established in Cambridge in 2008, Nuformix has invested into pharmaceutical cocrystal R&D, establishing world-class capability and know-how in cocrystal discovery and development, yielding multiple product opportunities with an accompanying portfolio of intellectual property.

Visit website

Quality amenities to suit all budgets

View our amenities